Fletcher Aaron G.L. - Jan 3, 2022 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CUE	Stock Option (right to buy)	Award	$0	+10K		$0.00	10K	Jan 3, 2022	Common Stock	10K	$12.28	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
F2	This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date.